, Haemochromatosis, The Lancet, vol.388, issue.10045, pp.706-716, 2016.
DOI : 10.1016/S0140-6736(15)01315-X
URL : https://hal.archives-ouvertes.fr/hal-01295665
, Non-transferrin bound iron: A key role in iron overload and iron toxicity, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1820, issue.3, pp.403-413, 2012.
DOI : 10.1016/j.bbagen.2011.07.014
URL : https://hal.archives-ouvertes.fr/hal-00739430
, Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases, Hepatology, vol.23, issue.5 Suppl 1, pp.328-371, 2011.
DOI : 10.1155/2009/839308
, Current Approaches to the Management of Hemochromatosis, Hematology, vol.2006, issue.1
DOI : 10.1182/asheducation-2006.1.36
URL : http://asheducationbook.hematologylibrary.org/content/2006/1/36.full.pdf
, EASL clinical practice guidelines for HFE hemochromatosis, J Hepatol, vol.53, pp.3-22, 2010.
, Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis, Neth J Med, vol.65, pp.452-457, 2007.
, A survey of 2,851 patients with hemochromatosis:, The American Journal of Medicine, vol.106, issue.6, pp.619-643, 1999.
DOI : 10.1016/S0002-9343(99)00120-5
, Haemochromatosis: The bone and the joint, Best Practice & Research Clinical Rheumatology, vol.25, issue.5, pp.649-664, 2011.
DOI : 10.1016/j.berh.2011.10.014
URL : https://hal.archives-ouvertes.fr/hal-00739810
, The effect of arthritis on the quality of life in hereditary hemochromatosis, J Rheumatol, vol.23, pp.707-717, 1996.
, Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.682-691, 2015.
DOI : 10.1016/j.jhep.2014.10.025
URL : https://hal.archives-ouvertes.fr/hal-01091479
, Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis, Gastroenterology, vol.115, issue.4, pp.929-965, 1998.
DOI : 10.1016/S0016-5085(98)70265-3
, Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.664-72, 2015.
DOI : 10.1016/j.jhep.2014.10.017
URL : https://hal.archives-ouvertes.fr/hal-01091987
, Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production, Hepatology, vol.281, issue.Suppl 1, pp.1784-92, 2013.
DOI : 10.1074/jbc.M513276200
URL : https://hal.archives-ouvertes.fr/inserm-00834268
, Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH, Gastroenterology, vol.131, issue.3, pp.788-96, 2006.
DOI : 10.1053/j.gastro.2006.07.007
, Increased Expression of Hepcidin in Obese Patients: Impact on Phenotypic Expression of Hemochromatosis and Pathophysiology of Dysmetabolic Iron Overload Syndrome, Gastroenterology, vol.131, issue.6, p.2028, 2006.
DOI : 10.1053/j.gastro.2006.10.046
, Hepcidin: regulation of the master iron regulator, Bioscience Reports, vol.84, issue.3, 2015.
DOI : 10.1182/blood-2013-07-515957
URL : http://www.bioscirep.org/content/ppbioscirep/35/3/e00192.full.pdf
, Serum Ferritin as a Component of the Insulin Resistance Syndrome, Diabetes Care, vol.21, issue.1, pp.62-70, 1998.
DOI : 10.2337/diacare.21.1.62
, Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis, Arthritis & Rheumatism, vol.61, issue.4, pp.799-806, 1999.
DOI : 10.1002/1529-0131(199904)42:4<799::AID-ANR25>3.0.CO;2-4
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/1529-0131%28199904%2942%3A4%3C799%3A%3AAID-ANR25%3E3.0.CO%3B2-4
, Hereditary Hemochromatosis, New England Journal of Medicine, vol.358, issue.3, pp.221-251, 2008.
DOI : 10.1056/NEJMoa073286
, How I treat hemochromatosis, Blood, vol.116, issue.3, pp.317-342, 2010.
DOI : 10.1182/blood-2010-01-261875
URL : http://www.bloodjournal.org/content/bloodjournal/116/3/317.full.pdf
, Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment, Gastroenterology, vol.139, issue.2, pp.393-408, 2010.
DOI : 10.1053/j.gastro.2010.06.013
, Musculoskeletal disease burden of hereditary hemochromatosis, Arthritis & Rheumatism, vol.35, issue.12, pp.3792-3800, 2010.
DOI : 10.1007/s002770100371
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.27712/pdf
, Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis, Rheumatology, vol.66, issue.11, pp.760-766, 2010.
DOI : 10.1136/ard.2006.063099
, Mechanisms and Functions of Inflammasomes, Cell, vol.157, issue.5, pp.1013-1035, 2014.
DOI : 10.1016/j.cell.2014.04.007
URL : https://doi.org/10.1016/j.cell.2014.04.007
, Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands, Annals of the Rheumatic Diseases, vol.72, issue.5, pp.783-787, 2013.
DOI : 10.1136/annrheumdis-2012-202738
, Activation of the NLRP3 inflammasome by cellular labile iron, Experimental Hematology, vol.44, issue.2, 2015.
DOI : 10.1016/j.exphem.2015.11.002
, Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method, Journal of Hepatology, vol.32, issue.5, pp.727-760, 2000.
DOI : 10.1016/S0168-8278(00)80240-8
, Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients, British Journal of Haematology, vol.106, issue.5, pp.692-698, 2014.
DOI : 10.1182/blood-2004-10-3982
URL : http://onlinelibrary.wiley.com/doi/10.1111/bjh.13081/pdf
, New insights into transfusion-related iron toxicity: Implications for the oncologist, Critical Reviews in Oncology/Hematology, vol.99, pp.261-71, 2016.
DOI : 10.1016/j.critrevonc.2015.11.017
, Redox active plasma iron in C282Y/C282Y hemochromatosis, Blood, vol.105, issue.11, pp.4527-4558, 2005.
DOI : 10.1182/blood-2004-09-3468
, Variables independently associated with worsening of MCP-PIP joints (n = 45/266) Odd ratio